We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$21B
AUM Growth
+$1.82B
Cap. Flow
+$406M
Cap. Flow %
1.93%
Top 10 Hldgs %
18.08%
Holding
144
New
8
Increased
70
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
STE icon
Steris
STE
+$339M
2
PLAN
Anaplan, Inc.
PLAN
+$138M
3
CSGP icon
CoStar Group
CSGP
+$86M
4
MRVI icon
Maravai LifeSciences
MRVI
+$67.7M
5
LESL icon
Leslie's
LESL
+$67.2M

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$320M
2
PFPT
Proofpoint, Inc.
PFPT
+$183M
3
CPB icon
Campbell Soup
CPB
+$135M
4
ULTA icon
Ulta Beauty
ULTA
+$63.1M
5
TECH icon
Bio-Techne
TECH
+$58.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Technology 20.7%
3 Industrials 14.5%
4 Consumer Staples 12.97%
5 Financials 12.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WASH icon
126
Washington Trust Bancorp
WASH
$748M
$38.4M 0.18%
748,310
+2,835
+0.4% +$149K
VAPO
127
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$35.9M 0.17%
189,646
+71,150
+60% +$12.1M
NVST icon
128
Envista
NVST
$4.62B
$34.6M 0.16%
801,610
-1,163,454
-59% -$50.5M
CCF
129
DELISTED
Chase Corporation
CCF
$33.1M 0.16%
322,505
-4,265
-1% -$472K
AIN icon
130
Albany International
AIN
$2.09B
$26.6M 0.13%
297,640
-15,255
-5% -$1.34M
SHAK icon
131
Shake Shack
SHAK
$2.54B
$22.7M 0.11%
+212,180
New +$21.4M
TRNS icon
132
Transcat
TRNS
$760M
$13.3M 0.06%
235,905
+88,545
+60% +$4.61M
API
133
Agora
API
$333M
$2.01M 0.01%
47,965
+28,865
+151% +$1.34M
ARCE
134
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$1.68M 0.01%
54,650
+8,300
+18% +$236K
DADA
135
DELISTED
Dada Nexus
DADA
$1.49M 0.01%
+51,315
New +$1.33M
BNR
136
Burning Rock Biotech
BNR
$93M
$887K ﹤0.01%
+3,010
New +$891K
MELI icon
137
Mercado Libre
MELI
$94.5B
$277K ﹤0.01%
178
– –
SE icon
138
Sea Limited
SE
$66.4B
$272K ﹤0.01%
990
– –
EPAM icon
139
EPAM Systems
EPAM
$5.58B
$212K ﹤0.01%
+415
New +$194K
BGS icon
140
B&G Foods
BGS
$303M
– –
-1,247,310
Closed -$38.7M
CPB icon
141
Campbell Soup
CPB
$6.85B
– –
-2,686,680
Closed -$135M
GTH
142
DELISTED
Genetron Holdings Limited ADS
GTH
– –
-14,438
Closed -$930K
PFPT
143
DELISTED
Proofpoint, Inc.
PFPT
– –
-1,453,900
Closed -$183M
CMD
144
DELISTED
Cantel Medical Corporation
CMD
– –
-4,005,675
Closed -$320M
2 3 4 5
6

Similar funds

PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Champlain Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Champlain Investment Partners held 144 positions worth $21B, up 9.5% from $19.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q2 2021 filing shows 8 new, 70 increased, 59 reduced and 5 closed positions. Its largest new stake was Steris: 1,685,437 shares worth $348M. The largest sale was Cantel Medical Corporation, an estimated $320M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q2 2021 buy was Steris: 1,685,437 shares worth $348M.
  • Champlain Investment Partners added most to Maravai LifeSciences in Q2 2021, an estimated $67.7M increase.
  • Champlain Investment Partners's biggest Q2 2021 reduction was Ulta Beauty, cutting an estimated $63.1M.
  • Champlain Investment Partners fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $320M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $21B portfolio in Q2 2021.
  • Champlain Investment Partners opened 8 new positions and closed 5 in Q2 2021.
  • Champlain Investment Partners's portfolio value rose 9.5% quarter-over-quarter to $21B.

Based on Champlain Investment Partners's 13F filing for Q2 2021, filed 12 Aug 2021.